| No. |
KEGG PATHWAY * On map, Yellow: Drug target, Red: Disease-related |
KEGG GENES * [Number of genes] |
KEGG DRUG * |
DrugBank |
Disease ID * [Number of diseases] |
| 1 | Acute myeloid leukemia 1 gene, 2 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 2 | Adherens junction 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
| 3 | Adipocytokine signaling pathway 3 genes, 3 drugs (DrugBank), 47 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 4 | Adrenergic signaling in cardiomyocytes 9 genes, 8 drugs (DrugBank), 23 diseases shown |
[3] ADRA1A, ADRA1B, ADRA1D |
D00608 |
Doxazosin |
[2] 57, 67 |
| D07874 |
| [1] ADRB1 |
D00634 |
Bisoprolol |
[3] 67, 86, 113 |
| D02342 |
| [1] AGTR1 |
D00522 |
Candesartan |
[2] 58, 67 |
| D00522 |
Candesartan cilexetil |
[2] 58, 67 |
| D00626 |
| D00357 |
Losartan |
[18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| D00627 |
Telmisartan |
[2] 66, 67 |
| [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00615 |
Amlodipine |
[4] 51, 65, 67, 298 |
| D02914 |
| D07450 |
| D01173 |
Cilnidipine |
[1] 67 |
| 5 | AGE-RAGE signaling pathway in diabetic complications 1 gene, 4 drugs (DrugBank), 18 diseases shown |
[1] AGTR1 |
D00522 |
Candesartan |
[2] 58, 67 |
| D00522 |
Candesartan cilexetil |
[2] 58, 67 |
| D00626 |
| D00357 |
Losartan |
[18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| D00627 |
Telmisartan |
[2] 66, 67 |
| 6 | Aldosterone synthesis and secretion 5 genes, 6 drugs (DrugBank), 21 diseases shown |
[1] AGTR1 |
D00522 |
Candesartan |
[2] 58, 67 |
| D00522 |
Candesartan cilexetil |
[2] 58, 67 |
| D00626 |
| D00357 |
Losartan |
[18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| D00627 |
Telmisartan |
[2] 66, 67 |
| [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00615 |
Amlodipine |
[4] 51, 65, 67, 298 |
| D02914 |
| D07450 |
| D01173 |
Cilnidipine |
[1] 67 |
| 7 | Aldosterone-regulated sodium reabsorption 1 gene, 1 drug (DrugBank), 6 diseases shown |
[1] NR3C2 |
D00443 |
Spironolactone |
[6] 58, 67, 86, 113, 218, 225 |
| 8 | Alzheimer disease 4 genes, 2 drugs (DrugBank), 4 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00615 |
Amlodipine |
[4] 51, 65, 67, 298 |
| D02914 |
| D07450 |
| D01173 |
Cilnidipine |
[1] 67 |
| 9 | Amphetamine addiction 2 genes, 2 drugs (DrugBank), 4 diseases shown |
[2] CACNA1C, CACNA1D |
D00615 |
Amlodipine |
[4] 51, 65, 67, 298 |
| D02914 |
| D07450 |
| D01173 |
Cilnidipine |
[1] 67 |
| 10 | AMPK signaling pathway 6 genes, 6 drugs (DrugBank), 55 diseases shown |
[1] ADRA1A |
D00608 |
Doxazosin |
[2] 57, 67 |
| D07874 |
| [1] HMGCR |
D00893 |
Pravastatin |
[9] 13, 46, 49, 67, 79, 96, 164, 265, 333 |
| D08410 |
| [1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] PPARG |
D00945 |
Pioglitazone |
[17] 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
| D08378 |
| [2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 11 | Apelin signaling pathway 4 genes, 7 drugs (DrugBank), 54 diseases shown |
[1] AGTR1 |
D00522 |
Candesartan |
[2] 58, 67 |
| D00522 |
Candesartan cilexetil |
[2] 58, 67 |
| D00626 |
| D00357 |
Losartan |
[18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| D00627 |
Telmisartan |
[2] 66, 67 |
| [1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 12 | Arrhythmogenic right ventricular cardiomyopathy (ARVC) 4 genes, 2 drugs (DrugBank), 4 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00615 |
Amlodipine |
[4] 51, 65, 67, 298 |
| D02914 |
| D07450 |
| D01173 |
Cilnidipine |
[1] 67 |
| 13 | Autophagy - animal 3 genes, 3 drugs (DrugBank), 47 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 14 | Autophagy - other 1 gene, 2 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 15 | Axon guidance 2 genes, 1 drug (DrugBank), 2 diseases shown |
[2] ABL1, SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
| 16 | Bacterial invasion of epithelial cells 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
| 17 | beta-Alanine metabolism 1 gene, 1 drug (DrugBank), 1 disease shown |
[1] AOC3 |
D08044 |
Hydralazine |
[1] 67 |
| 18 | Bile secretion 2 genes, 2 drugs (DrugBank), 19 diseases shown |
[1] HMGCR |
D00893 |
Pravastatin |
[9] 13, 46, 49, 67, 79, 96, 164, 265, 333 |
| D08410 |
| [1] NR1H4 |
D00734 |
Ursodeoxycholic acid |
[12] 6, 8, 20, 67, 84, 93, 94, 95, 96, 97, 234, 299 |
| 19 | Bladder cancer 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
| 20 | Breast cancer 1 gene, 2 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 21 | C-type lectin receptor signaling pathway 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
| 22 | Calcium signaling pathway 10 genes, 8 drugs (DrugBank), 23 diseases shown |
[3] ADRA1A, ADRA1B, ADRA1D |
D00608 |
Doxazosin |
[2] 57, 67 |
| D07874 |
| [1] ADRB1 |
D00634 |
Bisoprolol |
[3] 67, 86, 113 |
| D02342 |
| [1] AGTR1 |
D00522 |
Candesartan |
[2] 58, 67 |
| D00522 |
Candesartan cilexetil |
[2] 58, 67 |
| D00626 |
| D00357 |
Losartan |
[18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| D00627 |
Telmisartan |
[2] 66, 67 |
| [5] CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D01173 |
Cilnidipine |
[1] 67 |
| [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00615 |
Amlodipine |
[4] 51, 65, 67, 298 |
| D02914 |
| D07450 |
| 23 | cAMP signaling pathway 8 genes, 6 drugs (DrugBank), 15 diseases shown |
[1] ADRB1 |
D00634 |
Bisoprolol |
[3] 67, 86, 113 |
| D02342 |
| [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00615 |
Amlodipine |
[4] 51, 65, 67, 298 |
| D02914 |
| D07450 |
| D01173 |
Cilnidipine |
[1] 67 |
| [3] SSTR1, SSTR2, SSTR5 |
D10147 |
Pasireotide |
[3] 67, 74, 75 |
| D07431 |
Somatostatin |
[2] 67, 78 |
| [1] SSTR2 |
D00442 |
Octreotide |
[8] 67, 75, 84, 85, 89, 96, 193, 227 |
| D06495 |
| 24 | Carbohydrate digestion and absorption 1 gene, 2 drugs (DrugBank), 4 diseases shown |
[1] CACNA1D |
D00615 |
Amlodipine |
[4] 51, 65, 67, 298 |
| D02914 |
| D07450 |
| D01173 |
Cilnidipine |
[1] 67 |
| 25 | Cardiac muscle contraction 4 genes, 2 drugs (DrugBank), 4 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00615 |
Amlodipine |
[4] 51, 65, 67, 298 |
| D02914 |
| D07450 |
| D01173 |
Cilnidipine |
[1] 67 |
| 26 | Cell cycle 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] ABL1 |
D03252 |
Bosutinib |
[2] 2, 67 |
| 27 | Cellular senescence 2 genes, 4 drugs (DrugBank), 38 diseases shown |
[1] CACNA1D |
D00615 |
Amlodipine |
[4] 51, 65, 67, 298 |
| D02914 |
| D07450 |
| D01173 |
Cilnidipine |
[1] 67 |
| [1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 28 | Central carbon metabolism in cancer 1 gene, 2 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 29 | cGMP-PKG signaling pathway 9 genes, 8 drugs (DrugBank), 23 diseases shown |
[3] ADRA1A, ADRA1B, ADRA1D |
D00608 |
Doxazosin |
[2] 57, 67 |
| D07874 |
| [1] ADRB1 |
D00634 |
Bisoprolol |
[3] 67, 86, 113 |
| D02342 |
| [1] AGTR1 |
D00522 |
Candesartan |
[2] 58, 67 |
| D00522 |
Candesartan cilexetil |
[2] 58, 67 |
| D00626 |
| D00357 |
Losartan |
[18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| D00627 |
Telmisartan |
[2] 66, 67 |
| [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00615 |
Amlodipine |
[4] 51, 65, 67, 298 |
| D02914 |
| D07450 |
| D01173 |
Cilnidipine |
[1] 67 |
| 30 | Chagas disease (American trypanosomiasis) 1 gene, 3 drugs (DrugBank), 8 diseases shown |
[1] ACE |
D08068 |
Imidapril |
[1] 67 |
| D00362 |
Lisinopril |
[5] 46, 66, 67, 113, 222 |
| D08131 |
| D00421 |
Ramipril |
[7] 46, 49, 66, 67, 113, 218, 257 |
| 31 | Chemokine signaling pathway 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
| 32 | Choline metabolism in cancer 1 gene, 2 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 33 | Cholinergic synapse 5 genes, 2 drugs (DrugBank), 4 diseases shown |
[5] CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D01173 |
Cilnidipine |
[1] 67 |
| [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00615 |
Amlodipine |
[4] 51, 65, 67, 298 |
| D02914 |
| D07450 |
| 34 | Chronic myeloid leukemia 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] ABL1 |
D03252 |
Bosutinib |
[2] 2, 67 |
| 35 | Circadian entrainment 2 genes, 2 drugs (DrugBank), 4 diseases shown |
[2] CACNA1C, CACNA1D |
D00615 |
Amlodipine |
[4] 51, 65, 67, 298 |
| D02914 |
| D07450 |
| D01173 |
Cilnidipine |
[1] 67 |
| 36 | Circadian rhythm 2 genes, 1 drug (DrugBank), 17 diseases shown |
[2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 37 | Colorectal cancer 1 gene, 2 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 38 | Cortisol synthesis and secretion 5 genes, 6 drugs (DrugBank), 21 diseases shown |
[1] AGTR1 |
D00522 |
Candesartan |
[2] 58, 67 |
| D00522 |
Candesartan cilexetil |
[2] 58, 67 |
| D00626 |
| D00357 |
Losartan |
[18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| D00627 |
Telmisartan |
[2] 66, 67 |
| [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00615 |
Amlodipine |
[4] 51, 65, 67, 298 |
| D02914 |
| D07450 |
| D01173 |
Cilnidipine |
[1] 67 |
| 39 | Cushing syndrome 5 genes, 6 drugs (DrugBank), 21 diseases shown |
[1] AGTR1 |
D00522 |
Candesartan |
[2] 58, 67 |
| D00522 |
Candesartan cilexetil |
[2] 58, 67 |
| D00626 |
| D00357 |
Losartan |
[18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| D00627 |
Telmisartan |
[2] 66, 67 |
| [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00615 |
Amlodipine |
[4] 51, 65, 67, 298 |
| D02914 |
| D07450 |
| D01173 |
Cilnidipine |
[1] 67 |
| 40 | Dilated cardiomyopathy (DCM) 5 genes, 3 drugs (DrugBank), 6 diseases shown |
[1] ADRB1 |
D00634 |
Bisoprolol |
[3] 67, 86, 113 |
| D02342 |
| [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00615 |
Amlodipine |
[4] 51, 65, 67, 298 |
| D02914 |
| D07450 |
| D01173 |
Cilnidipine |
[1] 67 |
| 41 | Dopaminergic synapse 3 genes, 2 drugs (DrugBank), 4 diseases shown |
[3] CACNA1B, CACNA1C, CACNA1D |
D01173 |
Cilnidipine |
[1] 67 |
| [2] CACNA1C, CACNA1D |
D00615 |
Amlodipine |
[4] 51, 65, 67, 298 |
| D02914 |
| D07450 |
| 42 | EGFR tyrosine kinase inhibitor resistance 2 genes, 3 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
| 43 | Endocrine resistance 2 genes, 3 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
| 44 | Endocytosis 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
| 45 | Epithelial cell signaling in Helicobacter pylori infection 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
| 46 | ErbB signaling pathway 3 genes, 3 drugs (DrugBank), 37 diseases shown |
[2] ABL1, SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
| [1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 47 | Estrogen signaling pathway 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
| 48 | Fluid shear stress and atherosclerosis 3 genes, 2 drugs (DrugBank), 18 diseases shown |
[2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| [1] SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
| 49 | Focal adhesion 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
| 50 | FoxO signaling pathway 2 genes, 1 drug (DrugBank), 17 diseases shown |
[2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 51 | GABAergic synapse 6 genes, 3 drugs (DrugBank), 5 diseases shown |
[5] CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D01173 |
Cilnidipine |
[1] 67 |
| [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00615 |
Amlodipine |
[4] 51, 65, 67, 298 |
| D02914 |
| D07450 |
| [1] SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
| 52 | Gap junction 2 genes, 2 drugs (DrugBank), 4 diseases shown |
[1] ADRB1 |
D00634 |
Bisoprolol |
[3] 67, 86, 113 |
| D02342 |
| [1] SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
| 53 | Gastric acid secretion 1 gene, 3 drugs (DrugBank), 10 diseases shown |
[1] SSTR2 |
D00442 |
Octreotide |
[8] 67, 75, 84, 85, 89, 96, 193, 227 |
| D06495 |
| D10147 |
Pasireotide |
[3] 67, 74, 75 |
| D07431 |
Somatostatin |
[2] 67, 78 |
| 54 | Gastric cancer 1 gene, 2 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 55 | Glioma 1 gene, 2 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 56 | Glucagon signaling pathway 2 genes, 1 drug (DrugBank), 17 diseases shown |
[2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 57 | Glutamatergic synapse 2 genes, 2 drugs (DrugBank), 4 diseases shown |
[2] CACNA1C, CACNA1D |
D00615 |
Amlodipine |
[4] 51, 65, 67, 298 |
| D02914 |
| D07450 |
| D01173 |
Cilnidipine |
[1] 67 |
| 58 | Glycine, serine and threonine metabolism 1 gene, 1 drug (DrugBank), 1 disease shown |
[1] AOC3 |
D08044 |
Hydralazine |
[1] 67 |
| 59 | GnRH secretion 4 genes, 2 drugs (DrugBank), 4 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00615 |
Amlodipine |
[4] 51, 65, 67, 298 |
| D02914 |
| D07450 |
| D01173 |
Cilnidipine |
[1] 67 |
| 60 | GnRH signaling pathway 5 genes, 3 drugs (DrugBank), 5 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00615 |
Amlodipine |
[4] 51, 65, 67, 298 |
| D02914 |
| D07450 |
| D01173 |
Cilnidipine |
[1] 67 |
| [1] SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
| 61 | Growth hormone synthesis, secretion and action 9 genes, 7 drugs (DrugBank), 44 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00615 |
Amlodipine |
[4] 51, 65, 67, 298 |
| D02914 |
| D07450 |
| D01173 |
Cilnidipine |
[1] 67 |
| [1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [4] SSTR1, SSTR2, SSTR3, SSTR5 |
D10147 |
Pasireotide |
[3] 67, 74, 75 |
| D07431 |
Somatostatin |
[2] 67, 78 |
| [1] SSTR2 |
D00442 |
Octreotide |
[8] 67, 75, 84, 85, 89, 96, 193, 227 |
| D06495 |
| 62 | Hepatitis B 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
| 63 | Hepatocellular carcinoma 1 gene, 2 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 64 | Herpes simplex virus 1 infection 2 genes, 3 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
| 65 | HIF-1 signaling pathway 1 gene, 2 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 66 | Human cytomegalovirus infection 2 genes, 3 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
| 67 | Human immunodeficiency virus 1 infection 1 gene, 2 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 68 | Human papillomavirus infection 1 gene, 2 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 69 | Huntington disease 1 gene, 1 drug (DrugBank), 17 diseases shown |
[1] PPARG |
D00945 |
Pioglitazone |
[17] 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
| D08378 |
| 70 | Hypertrophic cardiomyopathy (HCM) 7 genes, 6 drugs (DrugBank), 24 diseases shown |
[1] ACE |
D08068 |
Imidapril |
[1] 67 |
| D00362 |
Lisinopril |
[5] 46, 66, 67, 113, 222 |
| D08131 |
| D00421 |
Ramipril |
[7] 46, 49, 66, 67, 113, 218, 257 |
| [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00615 |
Amlodipine |
[4] 51, 65, 67, 298 |
| D02914 |
| D07450 |
| D01173 |
Cilnidipine |
[1] 67 |
| [2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 71 | Inflammatory mediator regulation of TRP channels 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
| 72 | Insulin resistance 3 genes, 3 drugs (DrugBank), 47 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 73 | Insulin secretion 4 genes, 2 drugs (DrugBank), 4 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00615 |
Amlodipine |
[4] 51, 65, 67, 298 |
| D02914 |
| D07450 |
| D01173 |
Cilnidipine |
[1] 67 |
| 74 | Insulin signaling pathway 3 genes, 3 drugs (DrugBank), 47 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 75 | JAK-STAT signaling pathway 1 gene, 2 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 76 | Kaposi sarcoma-associated herpesvirus infection 2 genes, 3 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
| 77 | Long-term potentiation 1 gene, 2 drugs (DrugBank), 4 diseases shown |
[1] CACNA1C |
D00615 |
Amlodipine |
[4] 51, 65, 67, 298 |
| D02914 |
| D07450 |
| D01173 |
Cilnidipine |
[1] 67 |
| 78 | Longevity regulating pathway 4 genes, 4 drugs (DrugBank), 51 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] PPARG |
D00945 |
Pioglitazone |
[17] 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
| D08378 |
| [2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 79 | Longevity regulating pathway - multiple species 3 genes, 3 drugs (DrugBank), 47 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 80 | MAPK signaling pathway 5 genes, 2 drugs (DrugBank), 4 diseases shown |
[5] CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D01173 |
Cilnidipine |
[1] 67 |
| [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00615 |
Amlodipine |
[4] 51, 65, 67, 298 |
| D02914 |
| D07450 |
| 81 | Metabolic pathways 3 genes, 3 drugs (DrugBank), 10 diseases shown |
[1] AOC3 |
D08044 |
Hydralazine |
[1] 67 |
| [1] HMGCR |
D00893 |
Pravastatin |
[9] 13, 46, 49, 67, 79, 96, 164, 265, 333 |
| D08410 |
| [1] UGCG |
D11633 |
Venglustat |
[2] 19, 67 |
| 82 | MicroRNAs in cancer 2 genes, 3 drugs (DrugBank), 37 diseases shown |
[1] ABL1 |
D03252 |
Bosutinib |
[2] 2, 67 |
| [1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 83 | Mitophagy - animal 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
| 84 | Morphine addiction 1 gene, 1 drug (DrugBank), 1 disease shown |
[1] CACNA1B |
D01173 |
Cilnidipine |
[1] 67 |
| 85 | mTOR signaling pathway 3 genes, 3 drugs (DrugBank), 47 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 86 | Neuroactive ligand-receptor interaction 11 genes, 11 drugs (DrugBank), 29 diseases shown |
[3] ADRA1A, ADRA1B, ADRA1D |
D00608 |
Doxazosin |
[2] 57, 67 |
| D07874 |
| [1] ADRB1 |
D00634 |
Bisoprolol |
[3] 67, 86, 113 |
| D02342 |
| [1] AGTR1 |
D00522 |
Candesartan |
[2] 58, 67 |
| D00522 |
Candesartan cilexetil |
[2] 58, 67 |
| D00626 |
| D00357 |
Losartan |
[18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| D00627 |
Telmisartan |
[2] 66, 67 |
| [1] AVPR2 |
D04752 |
Lixivaptan |
[1] 67 |
| D01213 |
Tolvaptan |
[3] 67, 72, 225 |
| [5] SSTR1, SSTR2, SSTR3, SSTR4, SSTR5 |
D07431 |
Somatostatin |
[2] 67, 78 |
| [4] SSTR1, SSTR2, SSTR3, SSTR5 |
D10147 |
Pasireotide |
[3] 67, 74, 75 |
| [1] SSTR2 |
D00442 |
Octreotide |
[8] 67, 75, 84, 85, 89, 96, 193, 227 |
| D06495 |
| 87 | Neurotrophin signaling pathway 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] ABL1 |
D03252 |
Bosutinib |
[2] 2, 67 |
| 88 | Nicotine addiction 1 gene, 1 drug (DrugBank), 1 disease shown |
[1] CACNA1B |
D01173 |
Cilnidipine |
[1] 67 |
| 89 | Non-alcoholic fatty liver disease (NAFLD) 2 genes, 1 drug (DrugBank), 17 diseases shown |
[2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 90 | Osteoclast differentiation 1 gene, 1 drug (DrugBank), 17 diseases shown |
[1] PPARG |
D00945 |
Pioglitazone |
[17] 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
| D08378 |
| 91 | Oxytocin signaling pathway 7 genes, 4 drugs (DrugBank), 21 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00615 |
Amlodipine |
[4] 51, 65, 67, 298 |
| D02914 |
| D07450 |
| D01173 |
Cilnidipine |
[1] 67 |
| [2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| [1] SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
| 92 | Pancreatic cancer 1 gene, 2 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 93 | Pathogenic Escherichia coli infection 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] ABL1 |
D03252 |
Bosutinib |
[2] 2, 67 |
| 94 | Pathways in cancer 4 genes, 8 drugs (DrugBank), 53 diseases shown |
[1] ABL1 |
D03252 |
Bosutinib |
[2] 2, 67 |
| [1] AGTR1 |
D00522 |
Candesartan |
[2] 58, 67 |
| D00522 |
Candesartan cilexetil |
[2] 58, 67 |
| D00626 |
| D00357 |
Losartan |
[18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| D00627 |
Telmisartan |
[2] 66, 67 |
| [1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] PPARG |
D00945 |
Pioglitazone |
[17] 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
| D08378 |
| 95 | PD-L1 expression and PD-1 checkpoint pathway in cancer 1 gene, 2 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 96 | Phenylalanine metabolism 1 gene, 1 drug (DrugBank), 1 disease shown |
[1] AOC3 |
D08044 |
Hydralazine |
[1] 67 |
| 97 | Phospholipase D signaling pathway 3 genes, 8 drugs (DrugBank), 48 diseases shown |
[1] AGTR1 |
D00522 |
Candesartan |
[2] 58, 67 |
| D00522 |
Candesartan cilexetil |
[2] 58, 67 |
| D00626 |
| D00357 |
Losartan |
[18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| D00627 |
Telmisartan |
[2] 66, 67 |
| [1] AVPR2 |
D04752 |
Lixivaptan |
[1] 67 |
| D01213 |
Tolvaptan |
[3] 67, 72, 225 |
| [1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 98 | PI3K-Akt signaling pathway 3 genes, 3 drugs (DrugBank), 47 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 99 | Platelet activation 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
| 100 | PPAR signaling pathway 1 gene, 1 drug (DrugBank), 17 diseases shown |
[1] PPARG |
D00945 |
Pioglitazone |
[17] 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
| D08378 |
| 101 | Prolactin signaling pathway 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
| 102 | Prostate cancer 1 gene, 2 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 103 | Proteoglycans in cancer 2 genes, 3 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
| 104 | Rap1 signaling pathway 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
| 105 | Ras signaling pathway 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] ABL1 |
D03252 |
Bosutinib |
[2] 2, 67 |
| 106 | Regulation of actin cytoskeleton 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
| 107 | Regulation of lipolysis in adipocytes 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] ADRB1 |
D00634 |
Bisoprolol |
[3] 67, 86, 113 |
| D02342 |
| 108 | Relaxin signaling pathway 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
| 109 | Renin secretion 7 genes, 10 drugs (DrugBank), 25 diseases shown |
[1] ACE |
D08068 |
Imidapril |
[1] 67 |
| D00362 |
Lisinopril |
[5] 46, 66, 67, 113, 222 |
| D08131 |
| D00421 |
Ramipril |
[7] 46, 49, 66, 67, 113, 218, 257 |
| [1] ADRB1 |
D00634 |
Bisoprolol |
[3] 67, 86, 113 |
| D02342 |
| [1] AGTR1 |
D00522 |
Candesartan |
[2] 58, 67 |
| D00522 |
Candesartan cilexetil |
[2] 58, 67 |
| D00626 |
| D00357 |
Losartan |
[18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| D00627 |
Telmisartan |
[2] 66, 67 |
| [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00615 |
Amlodipine |
[4] 51, 65, 67, 298 |
| D02914 |
| D07450 |
| D01173 |
Cilnidipine |
[1] 67 |
| 110 | Renin-angiotensin system 2 genes, 7 drugs (DrugBank), 21 diseases shown |
[1] ACE |
D08068 |
Imidapril |
[1] 67 |
| D00362 |
Lisinopril |
[5] 46, 66, 67, 113, 222 |
| D08131 |
| D00421 |
Ramipril |
[7] 46, 49, 66, 67, 113, 218, 257 |
| [1] AGTR1 |
D00522 |
Candesartan |
[2] 58, 67 |
| D00522 |
Candesartan cilexetil |
[2] 58, 67 |
| D00626 |
| D00357 |
Losartan |
[18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| D00627 |
Telmisartan |
[2] 66, 67 |
| 111 | Retrograde endocannabinoid signaling 5 genes, 2 drugs (DrugBank), 4 diseases shown |
[5] CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D01173 |
Cilnidipine |
[1] 67 |
| [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00615 |
Amlodipine |
[4] 51, 65, 67, 298 |
| D02914 |
| D07450 |
| 112 | Salivary secretion 4 genes, 2 drugs (DrugBank), 4 diseases shown |
[3] ADRA1A, ADRA1B, ADRA1D |
D00608 |
Doxazosin |
[2] 57, 67 |
| D07874 |
| [1] ADRB1 |
D00634 |
Bisoprolol |
[3] 67, 86, 113 |
| D02342 |
| 113 | Serotonergic synapse 5 genes, 2 drugs (DrugBank), 4 diseases shown |
[5] CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D01173 |
Cilnidipine |
[1] 67 |
| [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00615 |
Amlodipine |
[4] 51, 65, 67, 298 |
| D02914 |
| D07450 |
| 114 | Shigellosis 3 genes, 3 drugs (DrugBank), 37 diseases shown |
[2] ABL1, SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
| [1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 115 | Sphingolipid metabolism 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] UGCG |
D11633 |
Venglustat |
[2] 19, 67 |
| 116 | Synaptic vesicle cycle 1 gene, 1 drug (DrugBank), 1 disease shown |
[1] CACNA1B |
D01173 |
Cilnidipine |
[1] 67 |
| 117 | Taste transduction 1 gene, 2 drugs (DrugBank), 4 diseases shown |
[1] CACNA1C |
D00615 |
Amlodipine |
[4] 51, 65, 67, 298 |
| D02914 |
| D07450 |
| D01173 |
Cilnidipine |
[1] 67 |
| 118 | Terpenoid backbone biosynthesis 1 gene, 1 drug (DrugBank), 9 diseases shown |
[1] HMGCR |
D00893 |
Pravastatin |
[9] 13, 46, 49, 67, 79, 96, 164, 265, 333 |
| D08410 |
| 119 | Th17 cell differentiation 1 gene, 2 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 120 | Thermogenesis 4 genes, 4 drugs (DrugBank), 51 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] PPARG |
D00945 |
Pioglitazone |
[17] 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
| D08378 |
| [2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 121 | Thyroid cancer 1 gene, 1 drug (DrugBank), 17 diseases shown |
[1] PPARG |
D00945 |
Pioglitazone |
[17] 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
| D08378 |
| 122 | Thyroid hormone signaling pathway 2 genes, 3 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
| 123 | Tight junction 4 genes, 4 drugs (DrugBank), 21 diseases shown |
[1] CACNA1D |
D00615 |
Amlodipine |
[4] 51, 65, 67, 298 |
| D02914 |
| D07450 |
| D01173 |
Cilnidipine |
[1] 67 |
| [2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| [1] SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
| 124 | Transcriptional misregulation in cancer 1 gene, 1 drug (DrugBank), 17 diseases shown |
[1] PPARG |
D00945 |
Pioglitazone |
[17] 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
| D08378 |
| 125 | Tuberculosis 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
| 126 | Type II diabetes mellitus 4 genes, 4 drugs (DrugBank), 38 diseases shown |
[3] CACNA1B, CACNA1C, CACNA1D |
D01173 |
Cilnidipine |
[1] 67 |
| [2] CACNA1C, CACNA1D |
D00615 |
Amlodipine |
[4] 51, 65, 67, 298 |
| D02914 |
| D07450 |
| [1] MTOR |
D02714 |
Everolimus |
[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 127 | Tyrosine metabolism 1 gene, 1 drug (DrugBank), 1 disease shown |
[1] AOC3 |
D08044 |
Hydralazine |
[1] 67 |
| 128 | Vascular smooth muscle contraction 8 genes, 7 drugs (DrugBank), 22 diseases shown |
[3] ADRA1A, ADRA1B, ADRA1D |
D00608 |
Doxazosin |
[2] 57, 67 |
| D07874 |
| [1] AGTR1 |
D00522 |
Candesartan |
[2] 58, 67 |
| D00522 |
Candesartan cilexetil |
[2] 58, 67 |
| D00626 |
| D00357 |
Losartan |
[18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| D00627 |
Telmisartan |
[2] 66, 67 |
| [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00615 |
Amlodipine |
[4] 51, 65, 67, 298 |
| D02914 |
| D07450 |
| D01173 |
Cilnidipine |
[1] 67 |
| 129 | Vasopressin-regulated water reabsorption 1 gene, 2 drugs (DrugBank), 3 diseases shown |
[1] AVPR2 |
D04752 |
Lixivaptan |
[1] 67 |
| D01213 |
Tolvaptan |
[3] 67, 72, 225 |
| 130 | VEGF signaling pathway 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
| 131 | Viral carcinogenesis 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] SRC |
D03252 |
Bosutinib |
[2] 2, 67 |
| 132 | Viral myocarditis 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] ABL1 |
D03252 |
Bosutinib |
[2] 2, 67 |
| 133 | Yersinia infection 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] SRC |
D03252 |
Bosutinib |
[2] 2, 67 |